...
首页> 外文期刊>Clinical transplantation. >Kidney allograft survival outcomes in combined intestinal‐kidney transplant: An analysis of the UNOS UNOS / OPTN OPTN database 2000‐2014
【24h】

Kidney allograft survival outcomes in combined intestinal‐kidney transplant: An analysis of the UNOS UNOS / OPTN OPTN database 2000‐2014

机译:联合肠肾移植组合的肾同种异体移植物生存结果:UNOS ens / OPTN OPTN数据库2000-2014的分析

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background and objectives Intestinal transplants carry a high morbidity/mortality. Kidney allograft outcomes after combined intestinal ( IT ) with kidney transplant ( CIKT ) remain largely uninvestigated. Materials and methods The UNOS STAR database was queried to identify all such combined organ transplants from 2000 to 2015. Results Out of a total 2215 (51.4% peds vs 48.6% adults) intestinal transplants, 111 (5.0%) CIKT were identified (32.4% peds vs 67.6% adults). Over the study period of CIKT , a total of 45.9% of these cases died with a functioning kidney graft. DGF rate was 9.0%. The 1‐year reported kidney acute rejection rate was 6.3%. For the entire CIKT population over the entire study era, the 1‐, 3‐, and 5‐year unadjusted kidney graft survival was 57%, 39%, and 34%, while death‐censored kidney graft survival was 93%, 90%, and 86%, respectively. Overall conditional 5‐year kidney graft survival (defined as 1‐year kidney graft survival) was 58%. Overall, patient survival was significantly lower in recipients of CIKT compared to intestinal transplant ( IT ) ( P ??.005); However, the 5‐year conditional (1?year kidney graft) patient survival in adults was not significantly different between IT and CIKT overall ( P ?=?.194). Conclusions Kidney allograft survival is primarily dependent on 1‐year patient survival. Guidelines regarding allocation of kidney allografts in CIKT need to take into consideration utility and urgency.
机译:摘要背景和目标肠移植患有高发病率/死亡率。与肾移植(CIKT)组合肠道(IT)后的肾同种异体移植结果仍然在大大未取消。材料和方法查询UNOS明星数据库,以识别2000年至2015年的所有此类组合器移植。总共2215(51.4%的PEDS对48.6%的成人)肠道移植物,鉴定了111(5.0%)CIKT(32.4% peds与67.6%的成年人)。在CIKT的研究时期,共有45.9%的这些病例与一个功能性肾移植物死亡。 DGF率为9.0%。 1年报告的肾急性排斥率为6.3%。对于整个学习时代的整个CIKT人口,1-,3-和5年的未调整的肾移植存活率为57%,39%和34%,而死亡咳嗽嫁接生存率为93%,90%分别为86%。整体条件5年肾移植存活(定义为1年肾移植物存活)为58%。总体而言,与肠移植(IT)相比,CIKT受者的患者存活率显着降低(P 1。005);然而,成人生存的5年条件(1?年肾脏移植物)患者生存并没有显着差异,总体而言和CIKT(P?= 194)。结论肾同种异体移植物存活主要依赖于1年的患者存活。关于CIKT肾同种异体移植物的分配指南需要考虑效用和紧迫性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号